Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Sequential targeting in multiple myeloma: talquetamab, a GPRC5D bispecific antibody, as a bridge to BCMA CAR-T therapy
PaperCitations, authors & open-access status
Sequential targeting in multiple myeloma: talquetamab, a GPRC5D bispecific antibody, as a bridge to BCMA CAR-T therapy is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 30 citations, 2025 year and closed oa status.
30
Citations
2025
Year
closed
OA Status